kynurenine has been researched along with Graves Ophthalmopathy in 1 studies
Kynurenine: A metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway.
kynurenine : A ketone that is alanine in which one of the methyl hydrogens is substituted by a 2-aminobenzoyl group.
Graves Ophthalmopathy: An autoimmune disorder of the EYE, occurring in patients with Graves disease. Subtypes include congestive (inflammation of the orbital connective tissue), myopathic (swelling and dysfunction of the extraocular muscles), and mixed congestive-myopathic ophthalmopathy.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This work aimed to characterize the kynurenine pathway, activated during interferon-γ (IFN-γ)-mediated inflammation and cellular (T-helper type 1 [Th1] type) immunity, in GD patients with and without thyroid eye disease (TED)." | 8.31 | Systemic Activation of the Kynurenine Pathway in Graves Disease With and Without Ophthalmopathy. ( Breivik, LE; Husebye, E; Løvås, K; Nilsen, RM; Rødahl, E; Stokland, AM; Ueland, GÅ; Ueland, HO; Ulvik, A; Wolff, ASB, 2023) |
| "This work aimed to characterize the kynurenine pathway, activated during interferon-γ (IFN-γ)-mediated inflammation and cellular (T-helper type 1 [Th1] type) immunity, in GD patients with and without thyroid eye disease (TED)." | 4.31 | Systemic Activation of the Kynurenine Pathway in Graves Disease With and Without Ophthalmopathy. ( Breivik, LE; Husebye, E; Løvås, K; Nilsen, RM; Rødahl, E; Stokland, AM; Ueland, GÅ; Ueland, HO; Ulvik, A; Wolff, ASB, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ueland, HO | 1 |
| Ulvik, A | 1 |
| Løvås, K | 1 |
| Wolff, ASB | 1 |
| Breivik, LE | 1 |
| Stokland, AM | 1 |
| Rødahl, E | 1 |
| Nilsen, RM | 1 |
| Husebye, E | 1 |
| Ueland, GÅ | 1 |
1 other study available for kynurenine and Graves Ophthalmopathy
| Article | Year |
|---|---|
Systemic Activation of the Kynurenine Pathway in Graves Disease With and Without Ophthalmopathy.
Topics: Biomarkers; Graves Disease; Graves Ophthalmopathy; Humans; Inflammation; Interferon-gamma; Kynurenin | 2023 |